Tiziana Life Sciences Ltd
TLSA | NASDAQ
$0.62
-$0.02 (-2.82%)
At close: Nov 5, 2026, 4:00 PM ET
$0.62
$0.00 (+0.53%)
After-hours:
Nov 5, 2026, 4:22 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 3.18M | 4.01M | 7.25M | 3.72M | 1.13M | 1.18M | 6.6M | 18.12M | 26.47M | 42.08M | 53.34M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 1.24M | 2.44M | 3.73M | 3.59M | 2.97M | 4.55M | 1.89M | 1.81M | 2.67M | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.38K |
Receivables | 4.32M | 4.26M | 4.95M | 3.69M | 6.27M | 6.05M | 7.89M | 5.99M | 4.9M | n/a | 2.77M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.94M | n/a | 517K | n/a | 355K | n/a | 691K | n/a | 4.89M | 5.29M | 1.11M |
Total Current Assets | 9.44M | 8.55M | 12.72M | 7.51M | 7.75M | 7.34M | 15.18M | 24.28M | 32.23M | 48.56M | 57.22M |
Property-Plant & Equipment | 985K | 499K | 150K | 187K | 245K | 293K | 351K | 389K | 12.96K | 16.96K | 580.33K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 117.67K | 129.67K | 134.03K |
Total Long-Term Assets | 2.22M | 2.94M | 3.88M | 3.78M | 3.21M | 4.85M | 2.24M | 2.2M | 2.8M | 146.63K | 715.74K |
Total Assets | 11.66M | 11.5M | 16.6M | 11.28M | 10.96M | 12.18M | 17.42M | 26.48M | 35.03M | 48.7M | 57.94M |
Account Payables | n/a | 7.17M | 5.23M | 5.58M | 7.48M | 4.14M | 2.95M | 4.96M | 4.41M | 4.39M | 3.81M |
Deferred Revenue | 343K | 530K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 106K | n/a | 107K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 728.18K |
Other Current Liabilities | 13.13M | -3K | 7.19M | 12K | 8K | 14K | 6K | 1.58M | 7.98K | 1.36M | 1.49M |
Total Current Liabilities | 13.58M | 11.21M | 7.4M | 7.35M | 9.07M | 6.54M | 3.94M | 6.66M | 5.26M | 7.53M | 8.75M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 420.05K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 826K | 234K | n/a | n/a | 37K | 109K | 183K | 243K | n/a | n/a | 420.05K |
Total Liabilities | 14.41M | 11.44M | 7.4M | 7.35M | 9.11M | 6.65M | 4.12M | 6.91M | 5.26M | 7.53M | 9.17M |
Total Debt | 932K | 456K | 107K | 106K | 179K | 247K | 353K | 365K | n/a | n/a | 1.15M |
Book Value | -2.75M | 52K | 9.2M | 3.94M | 1.86M | 5.54M | 13.3M | 19.57M | 29.76M | 41.18M | 48.76M |
Book Value Per Share | -0.04 | 0 | 0.16 | 0.07 | 0.04 | 0.11 | 0.26 | 0.39 | 0.59 | 0.37 | 0.65 |
Common Stock | 128K | 121K | 119K | 111K | 104K | 103K | 102K | 102K | 101.71K | 101.74K | 8.07M |
Retained Earnings | -56.8M | -44.41M | -31.77M | -144.83M | -138.27M | -133.68M | -124.88M | 2.43M | -112.26M | -107.79M | -103.49M |
Comprehensive Income | 10.48M | 9.68M | 9.06M | 116.99M | 116.99M | 117.06M | 117.27M | 2.76M | 127.17M | 133.31M | 31.91M |
Shareholders Equity | -2.75M | 52K | 9.2M | 3.94M | 1.86M | 5.54M | 13.3M | 19.57M | 29.76M | 41.18M | 48.76M |
Total Investments | 1.24M | 2.44M | 3.73M | 3.59M | 2.97M | 4.55M | 1.89M | 1.81M | 2.67M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TLSA